RUNX1-EVI1 appears to directly regulate a stem cell program establishing an immature phenotype associated with treatment resistance, (Eppert et al., 2011), expressing genes (MSI2 and ZEB1) regulating leukemia aggressiveness (Ito et al., 2010, Stavropoulou et al., 2016). This evidence concerns the gene MECOM and leukemia.